To include your compound in the COVID-19 Resource Center, submit it here.

Elagolix: Phase IIb data

The double-blind, international Phase IIb M12-813 trial in about 567 premenopausal women with heavy menstrual bleeding associated with uterine fibroids showed

Read the full 219 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE